SanBio Company Limited (SNBIF) Financials

SNBIF Assets vs Liabilities

DateAssetsLiabilities
July 31, 2026 85.3 million 12.0 million
April 30, 2026 92.3 million 11.7 million
Jan. 31, 2026 100.9 million 13.0 million
Oct. 31, 2025 15.6 million 12.4 million

SNBIF Free Cash Flow and Stock based compensation

No data available :(

SNBIF Net Income

No data available :(

SNBIF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
July 31, 2026 79.7 million 7.0 million -
April 30, 2026 89.0 million 7.1 million -
Jan. 31, 2026 97.5 million 7.2 million -
Oct. 31, 2025 12.4 million 7.2 million -

SNBIF Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
July 31, 2026 487852
April 30, 2026 ?
Jan. 31, 2026 504266
Oct. 31, 2025 ?

SNBIF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
July 31, 2026 - - - -
April 30, 2026 - 4.3 million 1.7 million -
Jan. 31, 2026 - 4.9 million 2.3 million -
Oct. 31, 2025 - 3.7 million 1.4 million -

SNBIF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
July 31, 2026 - -
April 30, 2026 - 25536
Jan. 31, 2026 - 14757
Oct. 31, 2025 - 12588

SNBIF

Price: $16.45

52 week price:
3.85
23.00

Earnings Per Share: -0.33 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.3 billion

Links: